MIA's annual Research Retreat 2021
20 August 2021
Today Melanoma Institute Australia (MIA) held its annual Research Retreat with more than 150 clinicians, researchers and MIA staff gathering online for a virtual event.
The Retreat shared highlights from MIA-led research activities as we continue to work towards our mission of zero deaths from melanoma.
Despite the constraints of COVID, research has continued to drive advances in melanoma treatment, detection, prevention and supportive care, as well as focusing on society, policy and economic impacts.
MIA's research is grouped into four themes:
- Early Melanoma - led by Prof Richard Scolyer AO and A/Prof Sydney Ch'ng
- Advanced Melanoma - led by Prof Georgina Long AO and Prof Helen Rizos
- Prevention, Risk and Clinical Detection - led by Prof Anne Cust and Prof Pascale Guitera
- Supportive Care and Survivorship - led by Dr Iris Batula and A/Prof Robyn Saw
- Society, Policy and Economics - led by Prof Rachael Morton & A/Prof Alex Menzies
Given our proud reputation as a world leader in melanoma research, it was appropriate that today’s inspiring program of presentations included a panel discussion on developing the next generation of melanoma research leaders.
Many thanks to our many research collaborators.
Read recently published research publications by the MIA team here.
Read about some of our active MIA research projects here.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.
Melanoma treatment has come a long way in recent times, and the role that nurses play caring for melanoma patients has changed dramatically too.
It was a massive weekend of Melanoma Marches with six Marches in: Bendigo, Canberra, Manly, Newcastle, Bunbury and Adelaide.